A Commentary on the NIH Consensus Development Statement 'Genetic Testing for Cystic Fibrosis'.
A NIH Consensus Development Statement recommends implementation of a cystic fibrosis carrier screening in the general pregnant and pre-pregnant population. This suggestion is discussed in the light of missing or insufficient data about the reasons for high uptake rates in pilot projects, psychological and social risks, and optimal educational and counselling settings. It is concluded that the recommendation is not defendable and, at best, premature.
Schmidtke
J
J
Institute of Human Genetics, Hannover Medical School, Hannover, Germany. schmidtke.joerg@mh-hannover.de